These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4233039)

  • 1. [Poliomyelitis: results of liver virus vaccination].
    Sabin AB
    Bol Oficina Sanit Panam; 1968 Jul; 65(1):52-61. PubMed ID: 4233039
    [No Abstract]   [Full Text] [Related]  

  • 2. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [International conference on tropical medicine "Medicine and health in the Tropics" September 11 to 15 2005. OPV versus IPV? Which vaccine is best to eradicate poliomyelitis?].
    Duhoux A; Vialan A; Buisson Y
    Med Trop (Mars); 2005 Nov; 65(5):430-1. PubMed ID: 16465805
    [No Abstract]   [Full Text] [Related]  

  • 4. Poliomyelitis vaccination for the international traveler.
    Mann JM; Bernier RH; Hinman AR
    Am Fam Physician; 1982 Dec; 26(6):135-9. PubMed ID: 7148637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradication.
    Hennessey KA; Marx A; Hafiz R; Ashgar H; Hadler SC; Jafari H; Sutter RW
    J Infect Dis; 2000 Jul; 182(1):6-11. PubMed ID: 10882575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of the antipoliomyelitis vaccination by living attenuated vaccine in a community of children infected by poliomyelitis virus type 1].
    de Lavercne E; Manciaux M; Olive D; Thomas R; Le Moyne MT
    Pathol Biol; 1965 May; 13(9):489-94. PubMed ID: 5320275
    [No Abstract]   [Full Text] [Related]  

  • 8. Virology. Poliomyelitis eradication--a dangerous endgame.
    Nathanson N; Fine P
    Science; 2002 Apr; 296(5566):269-70. PubMed ID: 11951020
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization against poliomyelitis: still problems to solve in both developed and developing countries.
    Hovi T
    Ann Clin Res; 1986; 18(3):119-20. PubMed ID: 3740787
    [No Abstract]   [Full Text] [Related]  

  • 10. [Poliomyelitis immunization].
    Vivell O
    Landarzt; 1967 May; 43(15):716-20. PubMed ID: 4305217
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral immunization against poliomyelitis].
    Haas R
    Dtsch Med Wochenschr; 1973 Sep; 98(36):1682-3. PubMed ID: 4741244
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis].
    Dostal V; Haenzel I; Sturm W
    Schweiz Med Wochenschr; 1969 Sep; 99(37):1322-4. PubMed ID: 4309326
    [No Abstract]   [Full Text] [Related]  

  • 15. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.
    Tebbens RJ; Pallansch MA; Kew OM; Cáceres VM; Jafari H; Cochi SL; Sutter RW; Aylward RB; Thompson KM
    Risk Anal; 2006 Dec; 26(6):1471-505. PubMed ID: 17184393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems of oral vaccination against poliomyelitis].
    Henneberg G
    Munch Med Wochenschr; 1969 Aug; 111(35):1701-8. PubMed ID: 5820235
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral polio vaccination in 5 vaccination periods. Consumption of vaccine and participation in vaccination].
    von Magnus H; Petersen I; Bentzon MW
    Ugeskr Laeger; 1973 Jan; 135(2):93-6. PubMed ID: 4702324
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the problem of the effect of vaccination against poliomyelitis].
    Adamová V
    Cesk Pediatr; 1969 Feb; 24(2):170-1. PubMed ID: 5783490
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunization with oral poliovirus vaccine in China.
    Dong DX
    Rev Infect Dis; 1984; 6 Suppl 2():S431. PubMed ID: 6740087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
    Alexander L; Birkhead G; Guerra F; Helms C; Hinman A; Katz S; LeBaron CW; Modlin J; Murphy TV; ;
    Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.